Product Information
BROMFENAC SODIUM 0.09% EYE DRP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $15.6341 per ML under NDC 62332050817. Its NADAC has been published 360 times since Nov 13, 2019.
FDA first approved this application on Jun 21, 2019. Its Orange Book therapeutic-equivalence code is AT2.
Strength
1.035 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332050817
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BROMFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA210560FDA Approved
6/21/2019
TE Code
AT2
On Market Since
6/21/2019
Pharmacological Classes
Price Statistics
The NADAC for BROMFENAC SODIUM 0.09% EYE DRP has been published 360 times since Nov 13, 2019, and over the history we have for it it has declined 84.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.6341 per ML |
|---|---|
| All-time high | $100.1941 (Nov 13, 2019) |
| All-time low | $15.1840 (Apr 22, 2026) |
| 52-week high | $22.2786 |
| 52-week low | $15.1840 |
| Median price | $62.7048 |
| Average price | $55.9931 |
| Largest weekly change | -52.1% (Apr 17, 2024) |
| Weeks tracked | 360 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bromfenac Ophthalmic Solution 0.09% market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bromfenac Ophthalmic Solution 0.09% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMFENAC SODIUM 0.09% EYE DRP?
The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.09% EYE DRP, manufactured by Alembic Pharmaceuticals Inc., is $15.6341 per ML (NDC 62332050817), effective Sep 30, 2026.
How has the price of BROMFENAC SODIUM 0.09% EYE DRP changed over time?
Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has declined 84.4%. It has been tracked across 360 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.09% EYE DRP?
Since Nov 13, 2019, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has ranged from a low of $15.1840 (Apr 22, 2026) to a high of $100.1941 (Nov 13, 2019), with a median of $62.7048 per ML.
Are there cheaper alternatives to BROMFENAC SODIUM 0.09% EYE DRP?
No other NADAC-published product currently shares the active ingredient and strength of BROMFENAC SODIUM 0.09% EYE DRP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BROMFENAC SODIUM 0.09% EYE DRP?
BROMFENAC SODIUM 0.09% EYE DRP (NDC 62332050817) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.